Evidence map›Paper›PMID 42719000›Full record

ArticleFrontiers in medicine2026

Clinical outcomes of residual branch vessel dissection following type A aortic dissection repair.

Jing Li, Siyuan Chen, Changying Zhao, Yang Yan

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jing LiDepartment of Cardiovascular Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Siyuan ChenDepartment of Cardiovascular Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Changying ZhaoDepartment of Cardiovascular Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yang YanDepartment of Cardiovascular Surgery, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Although aortic arch replacement eliminates the primary entry tear in type A aortic dissection, residual dissection in arch branch vessels (RD-ABV), often linked to fragile distal tissue or residual tears, may sustain false lumen patency and be related to post-discharge recovery. The clinical relevance of RD-ABV remains unclear. Methods: This retrospective cohort study included patients who underwent total arch replacement for aortic dissection between January 2018 and December 2024. Patients with in-hospital postoperative cerebral infarction, cerebral hemorrhage, or death were excluded, and follow-up began on the date of discharge. RD-ABV was assessed using the first postoperative CTA before discharge. The primary outcome was a composite event including modified Rankin Scale (mRS) 3-6, cerebral infarction (CI), cerebral hemorrhage (CH), and cardiovascular and cerebrovascular reoperation. Secondary outcomes included CI, CH, and reoperation. IPTW-adjusted win ratio was used for analyses of the primary and secondary composite outcomes. Results: A total of 564 patients were included, of whom 156 had RD-ABV. The IPTW-adjusted win ratio of the primary composite outcome was 0.47 (95% CI: 0.27-0.82; Conclusion: Among selected post-discharge survivors after aortic arch replacement, RD-ABV was associated with worse mid-term functional recovery, mainly reflected by mRS 3-6. The secondary composite outcome excluding mRS did not reach statistical significance. These findings should be interpreted as hypothesis-generating and require prospective validation.

Indexed as

aortic arch replacementlong-term prognosisresidual dissection in the arch branch vesselstype A aortic dissectionwin ratio analysis

Identifiers

PMID42719000
PMCPMC13553776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.